6:53 PM
 | 
Dec 07, 2017
 |  BC Week In Review  |  Company News  |  Deals

Bristol-Myers, Allied JV licenses immunoproteosome inhibitors from Cornell

Allied-Bristol Life Sciences formed ABLS IV, a new subsidiary which exclusively licensed immunoproteosome inhibitors from Weill Cornell Medical College...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >